Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - vildagliptinum, metformini hydrochloridum - compresse rivestite con film - vildagliptinum 50 mg metformini hydrochloridum 850 mg, hydroxypropylcellulosum, magnesio stearas, Überzug: hypromellosum, e 171, macrogolum 4000, talco, e 172 (giallo), per compresso haze. - farmaco antidiabetico orale - synthetika

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - vildagliptinum, metformini hydrochloridum - compresse rivestite con film - vildagliptinum 50.00 mg metformini hydrochloridum 1000.00 mg, hydroxypropylcellulosum, magnesio stearas, Überzug: hypromellosum, e 171, macrogolum 4000, talco, e 172 (giallo), per compresso haze. - farmaco antidiabetico orale - synthetika

Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

tecnigen s.r.l. - vildagliptin - vildagliptin

Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

doc generici srl - vildagliptin - vildagliptin

Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

accord healthcare, s.l.u. - vildagliptin - vildagliptin

Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

towa pharmaceutical s.p.a. - vildagliptin - vildagliptin

Italia - italiensk - AIFA (Agenzia Italiana del Farmaco)

pharmacare s.r.l. - vildagliptin - vildagliptin

Den europeiske union - italiensk - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - vildagliptinum - compresse - vildagliptinum 50.0 mg, cellulosum microcristallinum, lactosum 47.82 mg, carboxymethylamylum natricum a corresp. natrium max. 0.3 mg, magnesii stearas, pro compresso. - farmaco antidiabetico orale - synthetika

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - vildagliptinum, metformini hydrochloridum - compresse rivestite con film - vildagliptinum 50 mg metformini hydrochloridum 500 mg, hydroxypropylcellulosum, magnesio stearas, Überzug: hypromellosum, e 171, macrogolum 4000, talco, e 172 (giallo) e 172 (rosso), per compresso haze. - farmaco antidiabetico orale - synthetika